ES8707934A1 - Un procedimiento para la preparacion de derivados de piridina. - Google Patents

Un procedimiento para la preparacion de derivados de piridina.

Info

Publication number
ES8707934A1
ES8707934A1 ES555240A ES555240A ES8707934A1 ES 8707934 A1 ES8707934 A1 ES 8707934A1 ES 555240 A ES555240 A ES 555240A ES 555240 A ES555240 A ES 555240A ES 8707934 A1 ES8707934 A1 ES 8707934A1
Authority
ES
Spain
Prior art keywords
general formula
procedure
preparation
compound
piridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES555240A
Other languages
English (en)
Spanish (es)
Other versions
ES555240A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ES8707934A1 publication Critical patent/ES8707934A1/es
Publication of ES555240A0 publication Critical patent/ES555240A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES555240A 1985-05-23 1986-05-22 Un procedimiento para la preparacion de derivados de piridina. Expired ES8707934A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11064285 1985-05-23

Publications (2)

Publication Number Publication Date
ES8707934A1 true ES8707934A1 (es) 1987-09-01
ES555240A0 ES555240A0 (es) 1987-09-01

Family

ID=14540880

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555240A Expired ES8707934A1 (es) 1985-05-23 1986-05-22 Un procedimiento para la preparacion de derivados de piridina.

Country Status (14)

Country Link
US (1) US4691018A (2)
EP (1) EP0203435B1 (2)
JP (1) JPS6253966A (2)
KR (1) KR860008980A (2)
CN (1) CN86103501A (2)
AT (1) ATE55992T1 (2)
AU (1) AU587251B2 (2)
CA (1) CA1240332A (2)
DE (1) DE3673693D1 (2)
ES (1) ES8707934A1 (2)
HU (1) HU195486B (2)
SU (1) SU1419517A3 (2)
YU (1) YU83686A (2)
ZA (1) ZA863706B (2)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
US4904657A (en) * 1987-09-24 1990-02-27 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds exhibiting therapeutic activities
JP2746832B2 (ja) * 1993-05-14 1998-05-06 大鵬薬品工業株式会社 眼局所抗アレルギー剤
TW264385B (2) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
US20120195929A1 (en) * 2009-06-04 2012-08-02 George Eisenbarth Compounds that modulate autoimmunity and methods of using the same
US9629848B2 (en) 2011-05-26 2017-04-25 The Regents Of The University Of Colorado, A Body Corporate Compounds that modulate autoimmunity and methods of using the same
CN104582664B (zh) 2012-08-30 2018-04-20 亨特来夫工业技术有限公司 多层患者支撑覆盖薄板系统
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
US9820957B2 (en) 2016-03-24 2017-11-21 The Regents Of The University Of Colorado, A Body Corporate Methods of treating autoimmunity
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057797B1 (en) * 1981-02-03 1986-06-25 Imperial Chemical Industries Plc Process for the extraction of metal values and novel metal extractants
JPS58105920A (ja) * 1981-12-17 1983-06-24 Chugai Pharmaceut Co Ltd 抗癌剤
JPS58159465A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd ピリジン誘導体

Also Published As

Publication number Publication date
SU1419517A3 (ru) 1988-08-23
JPH0225906B2 (2) 1990-06-06
HU195486B (en) 1988-05-30
EP0203435B1 (en) 1990-08-29
ES555240A0 (es) 1987-09-01
AU587251B2 (en) 1989-08-10
DE3673693D1 (de) 1990-10-04
EP0203435A2 (en) 1986-12-03
YU83686A (en) 1988-06-30
ATE55992T1 (de) 1990-09-15
KR860008980A (ko) 1986-12-19
CN86103501A (zh) 1987-01-21
EP0203435A3 (en) 1988-01-07
JPS6253966A (ja) 1987-03-09
AU5726786A (en) 1986-11-27
CA1240332A (en) 1988-08-09
ZA863706B (en) 1987-01-28
HUT41735A (en) 1987-05-28
US4691018A (en) 1987-09-01

Similar Documents

Publication Publication Date Title
HUP9901319A2 (hu) 9-Hidroxi-riszperidon zsírsavészterek vizes szuszpenziói, előállításuk és alkalmazásuk
FR2377374A1 (fr) Derives acyles d'amino-acides et leur utilisation comme medicaments
IT1256345B (it) Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
ES2132076T3 (es) Pirroles sustituidos.
YU46023B (sh) Postupak za dobijanje novih analoga insulina
NO863935L (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
FR2354091A1 (fr) Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant
SE8301008L (sv) Pyrrolacetamider med antiinflammatorisk verkan
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
FR2360558A1 (fr) Nouveaux esters de l'epinine, utiles notamment en cardiotherapie, et leur procede de preparation
BG99729A (bg) Заместени 6-азаандростенони
FR2380285A1 (fr) Nouveaux derives insatures d'acides 7-acylamido-3-cephem-4-carboxyliques, utiles notamment comme agents antibacteriens, et leur procede de preparation
KR890701545A (ko) 건선치료를 위한 제약학적 조성물
EA199800155A1 (ru) Новое соединение
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
ITRM930365A0 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
GB1291864A (en) Mono thiachromone-2-carboxylic acids
ATE40793T1 (de) Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen.
FR2376150A1 (fr) Compositions therapeutiques a base de derives de l'hexahydro-1,2,3,3a,4,5-canthine
GB1195200A (en) Pharmaceutical Compositions.
ES2073189T3 (es) Derivados del acido fenoxialquilcarboxilico, procedimiento para su preparacion y agentes antialergicos.
ES2084348T3 (es) N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares.
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
DE3766334D1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.